Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Advanced NSCLC
NCT00003062Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1997
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Objective Response Rate. Started Jul 1997; status: completed.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003062.